"Ozempic breath" and taste disturbances. Patients report unusual symptoms

A recent study analyzed data from the FDA's FAERS database, focusing on GLP-1 receptor agonists and their oral health side effects. Over 31,000 reports indicated oral issues, with tirzepatide showing the highest number of adverse events. Semaglutide had the most complaints related to oral health, particularly dryness and taste disturbances. The study emphasizes the need for further research and awareness among patients regarding oral health while using these medications.